Management
Morten Albrechtsen
Chief Executive Officer (CEO)
Morten Albrechtsen is an MD and BBA (‘HD’ in marketing, CBS). Morten is a seasoned entrepreneur with a strong medical, commercial, and financial background. The expertise is gained within a broad range of therapeutic areas and with both drugs and devices. Morten has developed and launched new health care products and concepts internationally, e.g. in Nycomed Pharma, now Takeda Pharmaceuticals Ltd., Nanovi A/S and Boehringer Ingelheim GmbH.
Chief Executive Officer (CEO) since 2018
Number of FluoGuide shares 1,488,610 (owned via Wexotec ApS) and privately 128,750 warrants
Ole Larsen
Chief Financial Officer (CFO)
Ole Larsen holds a M.Sc. and is an experienced CFO with a strong history of working in various industries in both listed and unlisted companies, including Bavarian Nordic, BioPorto, Nordisk Film, and Berlingske Tidende. Ole is skilled in growth/start-ups, M&A and Corporate Finance, and has a finance professional background with a M.Sc. focused on Economics from Copenhagen Business School. Ole currently serves as member of the board at Linkfire.
Chief Financial Officer (CFO) since 2023
Number of FluoGuide shares 3,000 (owned via nuso ApS) and 64,200 warrants.
Jens Ellrich
Chief Medical Officer (CMO)
Jens Ellrich, brings over 30 years of extensive experience in translational neuroscience, medical devices, biotechnology, pharmacology, and digital therapeutics. His proven track record spans both academia and the start-up ecosystem, where he has successfully advanced innovative medical solutions across drugs, devices, and their combinations. Jens has played a key role in the development and launch of groundbreaking therapies at companies such as the Dutch Sapiens Steering Brain Stimulation acquired by Medtronic.
Chief Medical Officer (CMO) since 2024
Number of FluoGuide shares 0 and 15,000 warrants
Andreas Kjaer
Chief Scientific Officer (CSO)
Andreas Kjær is an MD, PhD, DMSc and professor at the University of Copenhagen and chief physician at Rigshospitalet, the National University Hospital of Denmark. His research is focused on molecular imaging with PET, PET/MRI and OPTICAL IMAGING in cancer and cardiovascular disease and his achievements include development of several new tracers that have reached first-in-humans clinical use. He is the holder of an ERC Advanced Grant, has published 700 peer-review articles and has received numerous prestigious scientific awards over the years. Andreas also has an MBA from Copenhagen Business School.
Chief Scientific Officer (CSO) since 2019
Number of FluoGuide shares 2,126,107 and 121,400 warrants (Partly owned via Life Science ApS)
Grethe Nørskov Rasmussen
Chief Development officer (CDO)
Grethe Nørskov Rasmussen holds a M.Sc. and PhD. Grethe Rasmussen is an experienced product developer with a profound understanding of CMC and former Senior Vice President Product Development at Ascendis Pharma A/S, where she worked for over 10 years. Previously, Grethe served as Vice President for Protein Science at Maxygen, Inc. and later as Managing Director for the Danish subsidiary of Maxygen. Prior to joining Maxygen, Grethe held various positions at Novo Nordisk A/S, a global healthcare company, where she contributed to research and development. Grethe holds a PhD in Biochemistry from the Danish Technical University.
Chief Development Officer (CDO) since 2019
Number of FluoGuide shares 343,185 and 46,050 warrants
Morten Albrechtsen
Chief Executive Officer (CEO)
Morten Albrechtsen is an MD and BBA (‘HD’ in marketing, CBS). Morten is a seasoned entrepreneur with a strong medical, commercial, and financial background. The expertise is gained within a broad range of therapeutic areas and with both drugs and devices. Morten has developed and launched new health care products and concepts internationally, e.g. in Nycomed Pharma, now Takeda Pharmaceuticals Ltd., Nanovi A/S and Boehringer Ingelheim GmbH.
Chief Executive Officer (CEO) since 2018
Number of FluoGuide shares 1,488,610 (owned via Wexotec ApS) and privately 128,750 warrants
Ole Larsen
Chief Financial Officer (CFO)
Ole Larsen holds a M.Sc. and is an experienced CFO with a strong history of working in various industries in both listed and unlisted companies, including Bavarian Nordic, BioPorto, Nordisk Film, and Berlingske Tidende. Ole is skilled in growth/start-ups, M&A and Corporate Finance, and has a finance professional background with a M.Sc. focused on Economics from Copenhagen Business School. Ole currently serves as member of the board at Linkfire.
Chief Financial Officer (CFO) since 2023
Number of FluoGuide shares 3,000 (owned via nuso ApS) and 64,200 warrants.
Jens Ellrich
Chief Medical Officer (CMO)
Jens Ellrich, brings over 30 years of extensive experience in translational neuroscience, medical devices, biotechnology, pharmacology, and digital therapeutics. His proven track record spans both academia and the start-up ecosystem, where he has successfully advanced innovative medical solutions across drugs, devices, and their combinations. Jens has played a key role in the development and launch of groundbreaking therapies at companies such as the Dutch Sapiens Steering Brain Stimulation acquired by Medtronic.
Chief Medical Officer (CMO) since 2024
Number of FluoGuide shares 0 and 15,000 warrants
Andreas Kjaer
Chief Scientific Officer (CSO)
Andreas Kjær is an MD, PhD, DMSc and professor at the University of Copenhagen and chief physician at Rigshospitalet, the National University Hospital of Denmark. His research is focused on molecular imaging with PET, PET/MRI and OPTICAL IMAGING in cancer and cardiovascular disease and his achievements include development of several new tracers that have reached first-in-humans clinical use. He is the holder of an ERC Advanced Grant, has published 700 peer-review articles and has received numerous prestigious scientific awards over the years. Andreas also has an MBA from Copenhagen Business School.
Chief Scientific Officer (CSO) since 2019
Number of FluoGuide shares 2,126,107 and 121,400 warrants (Partly owned via Life Science ApS)
Grethe Nørskov Rasmussen
Chief Development officer (CDO)
Grethe Nørskov Rasmussen holds a M.Sc. and PhD. Grethe Rasmussen is an experienced product developer with a profound understanding of CMC and former Senior Vice President Product Development at Ascendis Pharma A/S, where she worked for over 10 years. Previously, Grethe served as Vice President for Protein Science at Maxygen, Inc. and later as Managing Director for the Danish subsidiary of Maxygen. Prior to joining Maxygen, Grethe held various positions at Novo Nordisk A/S, a global healthcare company, where she contributed to research and development. Grethe holds a PhD in Biochemistry from the Danish Technical University.
Chief Development Officer (CDO) since 2019
Number of FluoGuide shares 343,185 and 46,050 warrants